Delivering accessible, multidisciplinary care to working-age adult cancer survivors through a virtual program.

517 Background: Approximately 30% of the 18 million cancer survivors in the U.S. are working-age adults (WAA): 21 to 65 years old. Despite distinct age-related health and psychosocial needs, the characteristics of WAA survivors are unclear, and access to expert, guideline-based survivorship care remains limited. To address this gap, we created a 50-state, oncologist-led, multidisciplinary virtual cancer survivorship clinic and report our early experience. Methods: All patients enrolled in the survivorship program are assigned an oncologist-led team that includes physicians, oncology nurse navigators, a registered dietitian, genetic counselors, trained care advocates and behavioral health specialists. The survivorship care model starts with a 60-minute telehealth visit with a survivorship physician who assesses the patient and develops a personalized, guideline-based care plan. Plans address cancer screening and surveillance, management of treatment related effects, psychosocial issues and financial concerns. Recommended studies and referrals were ordered, directly arranged on the patient’s behalf and followed by the team. We conducted a retrospective review of patients who self-identified as a cancer survivor, were eligible through an employer or union benefit and completed the initial survivorship visit between January 1, 2025 and June 4, 2025 and during the pilot phase starting November 15, 2024. Results: The cohort was comprised of 185 individuals with a median age of 53 years (range 20–75); T63.8% identified as female and 74.6% white. Patients were geographically disturbed across the United States: Midwest (27.6%), Northeast (26.5%), South (30.3%), West (15.7%); 8% resided in areas of high or medium social vulnerability. Survivors represented a wide range of industries, including consumer/industrial (45.9%), technology and professional services (15.7%), finance/real estate (14.6%), non-profit/government and education sectors (13.5%), and healthcare/life sciences (10.3%). Cancer types were diverse, with non-melanocytic skin (20.5%), breast (19.5%), and melanoma (11.3%) the most common. The median age at diagnosis was 43.0 years; and 56.3% were diagnosed within the past 10 years. The survivorship team provided a wide range of services including coordinating appointments, facilitating cancer screenings, genetic counseling, directing to psychosocial support, and helping people find a facility for a specific test or support group. On average, patients interacted with care team members 13.3 times (range 1-70). Among patients who rated their experience (9 = individuals, 13 responses), the average rating was 9.9 net promoter score. Conclusions: We describe a virtual team-based survivorship care program accessible to a diverse national cohort of WAA cancer survivors. Evaluation of program outcomes, including need assessment and care gap closure, is ongoing.